Showing results (161-170 of 268) with videos related to
Sort By:
Pageof 27
HIV Medicine|January 18, 2008
Regional differences in the risk of triple class failure in European patients starting combination antiretroviral therapy after 1 January 1999A Mocroft, A Horban, B Clotet, et al.AIDS (London, England)|December 12, 2001
Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patientsA N Phillips, C Pradier, A Lazzarin, et al.The Journal of Antimicrobial Chemotherapy|April 4, 2017
Variable endothelial cell function restoration after initiation of two antiretroviral regimens in HIV-infected individualsP Echeverría, E Gómez-Mora, S Roura, et al.AIDS (London, England)|June 21, 2001
HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infectionL Ruiz, G Carcelain, J Martínez-Picado, et al.HIV Medicine|May 20, 2008
Targeting only reverse transcriptase with zidovudine/lamivudine/abacavir plus tenofovir in HIV-1-infected patients with multidrug-resistant virus: a multicentre pilot studyJ M Llibre, A Bonjoch, J Iribarren, et al.Revista Clinica Espanola|February 1, 1995
[Liver tuberculous abscess in patients with human immunodeficiency virus infection: report of 2 cases and review of the literature]P Roig Rico, L Pérez Rodríguez, V Navarro Ibáñez, et al.Antiviral Therapy|February 22, 2000
Presence of genotypic resistance in nucleoside analogue-treated HIV-1-infected patients with undetectable viral loadA Rubio, M Gómez-Cano, T Puig, et al.Clinical and Experimental Immunology|August 16, 2006
Treatment of monocytes with interleukin (IL)-12 plus IL-18 stimulates survival, differentiation and the production of CXC chemokine ligands (CXCL)8, CXCL9 and CXCL10G Coma, R Peña, J Blanco, et al.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|September 10, 1998
Predictive factors influencing peak viral load drop in response to nucleoside reverse transcriptase inhibitors in antiretroviral-naive HIV-1-infected patientsC Vidal, F García, J M Gatell, et al.Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|November 14, 2018
Interleukin (IL) -1 β, IL-6 and tumor necrosis factor in patients with seasonal fluJ M Ramos, M García-Navarro, V Moreno, et al.Pageof 27